Novosteo, a Purdue University spin-out, has secured $500,000 in seed funding. The investor was Research Bridge Partners. Novosteo is developing a novel injectable-targeted drug for broken and compromised bones.
Source: Press Release
Nearly there!
We have just sent you an email so you can verify your account. Please check your spam or junk folder just in case it's been delivered there.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please email: customerservices@peimedia.com.-
Sign in or Register
-
Issues with signing in? Click here
Not yet registered? Register now
Become a subscriber, Subscribe now
-
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.
